PROCEPT BioRobotics Corp. (PRCT)
21.97
+1.06
(+5.07%)
USD |
NASDAQ |
Sep 02, 16:00
21.95
-0.02
(-0.09%)
After-Hours: 20:00
PROCEPT BioRobotics Research and Development Expense (TTM) : 77.19M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 77.19M |
| March 31, 2026 | 73.13M |
| December 31, 2025 | 68.07M |
| September 30, 2025 | 64.08M |
| June 30, 2025 | 62.83M |
| March 31, 2025 | 63.02M |
| December 31, 2024 | 58.52M |
| September 30, 2024 | 56.63M |
| June 30, 2024 | 51.86M |
| March 31, 2024 | 46.78M |
| December 31, 2023 | 44.32M |
| Date | Value |
|---|---|
| September 30, 2023 | 40.83M |
| June 30, 2023 | 36.42M |
| March 31, 2023 | 31.36M |
| December 31, 2022 | 26.92M |
| September 30, 2022 | 22.31M |
| June 30, 2022 | 21.09M |
| March 31, 2022 | 18.71M |
| December 31, 2021 | 18.22M |
| September 30, 2021 | 17.69M |
| June 30, 2021 | 16.66M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insulet Corp. | 345.90M |
| Globus Medical, Inc. | 147.06M |
| Abbott Laboratories | 3.128B |
| Alphatec Holdings, Inc. | 76.69M |
| Artivion, Inc. | 35.10M |